Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin‐evoked peripheral neuropathy. Issue 3 (1st March 2017)
- Record Type:
- Journal Article
- Title:
- Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin‐evoked peripheral neuropathy. Issue 3 (1st March 2017)
- Main Title:
- Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin‐evoked peripheral neuropathy
- Authors:
- Areti, Aparna
Komirishetty, Prashanth
Akuthota, Manasaveena
Malik, Rayaz A.
Kumar, Ashutosh - Abstract:
- Abstract: Oxaliplatin, an organoplatinum compound, is used in the treatment of colorectal cancer, but its clinical use can be limited due to the development of peripheral neuropathy. Whilst mitochondrial dysfunction has been implicated as a major pathomechanism for oxaliplatin‐induced neurotoxicity, the prevention of autophagy may also aggravate neuronal cell death. Melatonin, a well‐known mitoprotectant and autophagy inducer, was used to examine its neuroprotective role in oxaliplatin‐induced peripheral neuropathy (OIPN). Melatonin prevented the loss of mitochondrial membrane potential (Ψm) and promoted neuritogenesis in oxaliplatin‐challenged neuro‐2a cells. It did not interfere with the cytotoxic activity of oxaliplatin in human colon cancer cell line, HT‐29. Melatonin treatment significantly alleviated oxaliplatin‐induced pain behavior and neuropathic deficits in rats. It also ameliorated nitro‐oxidative stress mediated by oxaliplatin, thus prevented nitrosylation of proteins and loss of antioxidant enzymes, and therefore, it improved mitochondrial electron transport chain function and maintained cellular bioenergetics by improving the ATP levels. The protective effects of melatonin were attributed to preventing oxaliplatin‐induced neuronal apoptosis by increasing the autophagy pathway (via LC3A/3B) in peripheral nerves and dorsal root ganglion (DRG). Hence, it preserved the epidermal nerve fiber density in oxaliplatin‐induced neuropathic rats. Taken together, we provideAbstract: Oxaliplatin, an organoplatinum compound, is used in the treatment of colorectal cancer, but its clinical use can be limited due to the development of peripheral neuropathy. Whilst mitochondrial dysfunction has been implicated as a major pathomechanism for oxaliplatin‐induced neurotoxicity, the prevention of autophagy may also aggravate neuronal cell death. Melatonin, a well‐known mitoprotectant and autophagy inducer, was used to examine its neuroprotective role in oxaliplatin‐induced peripheral neuropathy (OIPN). Melatonin prevented the loss of mitochondrial membrane potential (Ψm) and promoted neuritogenesis in oxaliplatin‐challenged neuro‐2a cells. It did not interfere with the cytotoxic activity of oxaliplatin in human colon cancer cell line, HT‐29. Melatonin treatment significantly alleviated oxaliplatin‐induced pain behavior and neuropathic deficits in rats. It also ameliorated nitro‐oxidative stress mediated by oxaliplatin, thus prevented nitrosylation of proteins and loss of antioxidant enzymes, and therefore, it improved mitochondrial electron transport chain function and maintained cellular bioenergetics by improving the ATP levels. The protective effects of melatonin were attributed to preventing oxaliplatin‐induced neuronal apoptosis by increasing the autophagy pathway (via LC3A/3B) in peripheral nerves and dorsal root ganglion (DRG). Hence, it preserved the epidermal nerve fiber density in oxaliplatin‐induced neuropathic rats. Taken together, we provide detailed molecular mechanisms for the neuroprotective effect of melatonin and suggest it has translational potential for oxaliplatin‐induced neuropathy. Abstract : Schematic model of mitoprotective and neuroprotective mechanisms of melatonin against oxaliplatin‐evoked peripheral neuropathy. … (more)
- Is Part Of:
- Journal of pineal research. Volume 62:Issue 3(2017)
- Journal:
- Journal of pineal research
- Issue:
- Volume 62:Issue 3(2017)
- Issue Display:
- Volume 62, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 62
- Issue:
- 3
- Issue Sort Value:
- 2017-0062-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2017-03-01
- Subjects:
- autophagy -- melatonin -- mitochondrial dysfunction -- oxaliplatin -- oxidative/nitrosative stress -- peripheral neuropathy
Pineal gland -- Periodicals
Pineal Gland -- Periodicals
Épiphyse (Glande)
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
612.492 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-079X ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jpi ↗
http://www.blackwellpublishing.com/journal.asp?ref=0742-3098&site=1 ↗
http://www.ingenta.com/journals/browse/mksg/jpi?mode=direct ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jpi.12393 ↗
- Languages:
- English
- ISSNs:
- 0742-3098
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5040.329000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 163.xml